Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.453
+0.053 (2.22%)
Aug 6, 2026, 10:32 AM EDT - Market open

Inhibikase Therapeutics Market Cap

Inhibikase Therapeutics has a market cap or net worth of $479.41 million as of August 6, 2026. Its market cap has increased by 195.91% in one year.

Market Cap
479.41M
Enterprise Value
298.64M
1-Year Change
195.91%
Ranking
Category
Stock Price
$2.45

Chart

Chart

Since the IPO on December 23, 2020, Inhibikase Therapeutics's market cap has increased from $100.46M to $479.41M, an increase of 377.23%. That is a compound annual growth rate of 32.05%.

History

DateMarket Cap% Change
Aug 6, 2026479.41M70.97%
Dec 31, 2025280.40M-3.25%
Dec 31, 2024289.83M3,596.14%
Dec 29, 20237.84M-37.83%
Dec 30, 202212.61M-65.89%
Dec 31, 202136.98M-46.68%
Dec 31, 2020 Pro Pro
Dec 23, 2020 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding